CN Stock MarketDetailed Quotes

000028 China National Accord Medicines Corporation

Watchlist
  • 31.80
  • +1.33+4.36%
Trading Nov 18 13:40 CST
17.70BMarket Cap12.00P/E (TTM)

China National Accord Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-0.21%56.47B
-1.57%37.79B
2.16%19.09B
2.77%75.48B
3.61%56.59B
6.25%38.39B
8.96%18.69B
7.44%73.44B
8.78%54.62B
8.94%36.13B
Operating revenue
-0.21%56.47B
-1.57%37.79B
2.16%19.09B
2.77%75.48B
3.61%56.59B
6.25%38.39B
8.96%18.69B
7.44%73.44B
8.78%54.62B
8.94%36.13B
Other operating revenue
----
8.14%413.53M
----
-14.71%633.35M
----
6.18%382.39M
----
4.59%742.57M
----
11.90%360.13M
Total operating cost
0.73%55.38B
-0.60%37.02B
2.54%18.63B
2.76%73.28B
3.41%54.98B
5.99%37.25B
8.15%18.17B
7.20%71.31B
8.75%53.17B
9.14%35.14B
Operating cost
0.56%50.33B
-0.87%33.64B
2.80%17.02B
2.96%66.43B
3.53%50.05B
6.25%33.94B
8.71%16.55B
6.92%64.52B
8.99%48.34B
9.32%31.94B
Operating tax surcharges
2.00%141.93M
6.00%96M
6.61%45.48M
-2.14%188.18M
-2.31%139.15M
-5.56%90.57M
1.71%42.66M
13.47%192.3M
20.03%142.43M
26.20%95.9M
Operating expense
2.52%3.94B
1.47%2.64B
0.11%1.26B
1.01%5.33B
2.58%3.84B
4.70%2.6B
4.78%1.26B
10.94%5.27B
7.37%3.75B
7.76%2.49B
Administration expense
-4.39%773.75M
-3.94%509.77M
-5.12%251.65M
-2.03%1.11B
3.49%809.31M
4.17%530.7M
0.27%265.24M
7.98%1.13B
2.89%781.99M
3.44%509.46M
Financial expense
47.51%183.06M
63.23%120.39M
8.10%45.59M
7.93%204.54M
-18.83%124.1M
-33.67%73.76M
-29.53%42.17M
-10.81%189.51M
-7.68%152.89M
3.69%111.2M
-Interest expense (Financial expense)
8.20%198.56M
21.10%131.09M
-7.17%54.75M
-5.16%248.38M
-10.49%183.51M
-24.23%108.24M
-18.67%58.98M
-9.07%261.91M
-7.54%205.02M
-2.85%142.86M
-Interest Income (Financial expense)
21.53%-46.62M
12.63%-35.05M
-5.69%-19.24M
-6.33%-77.55M
-11.73%-59.4M
-15.86%-40.12M
-8.53%-18.2M
1.83%-72.94M
9.42%-53.17M
10.66%-34.63M
Research and development
7.16%19.24M
7.72%12.97M
180.75%6.26M
195.81%26.82M
--17.96M
--12.04M
--2.23M
--9.07M
----
----
Credit Impairment Loss
46.24%-46.93M
55.64%-27.36M
14.17%-40.85M
-256.30%-77M
-52.10%-87.28M
-39.41%-61.69M
-83.77%-47.59M
49.50%-21.61M
-81.87%-57.39M
-54.37%-44.25M
Asset Impairment Loss
-24.43%-10.76M
-284.69%-9.74M
27.74%-1.81M
75.45%-17.58M
19.82%-8.65M
61.04%-2.53M
-51.64%-2.51M
70.53%-71.59M
-1,099.11%-10.79M
-1,458.75%-6.5M
Other net revenue
20.34%262.69M
20.70%186.9M
45.44%82M
54.70%267.04M
90.53%218.29M
240.00%154.84M
157.10%56.38M
50.96%172.62M
-57.91%114.57M
-73.85%45.54M
Fair value change income
-81.93%3.15M
-81.93%3.15M
----
-152.51%-15.16M
--17.43M
--17.43M
----
--28.87M
----
----
Invest income
12.27%254.93M
22.09%190.06M
17.13%102.74M
70.36%237.03M
103.50%227.06M
218.09%155.67M
273.86%87.71M
-52.41%139.13M
-51.95%111.58M
-68.75%48.94M
-Including: Investment income associates
33.55%310.43M
44.83%227.27M
42.41%110.34M
5.67%315.45M
29.98%232.45M
58.72%156.92M
86.33%77.48M
-10.46%298.53M
-24.85%178.84M
-37.30%98.87M
Asset deal income
-37.29%6.76M
-49.84%4.03M
69.31%3.01M
445.31%45.31M
67.65%10.78M
151.82%8.04M
81.57%1.78M
95.71%8.31M
566.74%6.43M
642.26%3.19M
Other revenue
-5.80%55.53M
-29.44%26.76M
11.32%18.91M
5.51%94.44M
-8.93%58.95M
-14.12%37.92M
-32.15%16.99M
-13.45%89.51M
-6.82%64.74M
-6.54%44.16M
Operating profit
-26.25%1.34B
-26.74%948.86M
-5.61%544M
7.00%2.47B
16.54%1.82B
25.45%1.3B
53.66%576.35M
18.11%2.31B
-1.81%1.56B
-9.21%1.03B
Add:Non operating Income
139.75%21.91M
118.95%12.97M
137.14%8.15M
96.22%24.45M
-0.28%9.14M
36.02%5.93M
50.18%3.44M
-65.73%12.46M
-43.37%9.16M
-65.13%4.36M
Less:Non operating expense
-14.78%9.89M
-58.81%3.87M
46.00%1.9M
150.01%18.65M
189.62%11.61M
328.13%9.38M
116.85%1.3M
-46.42%7.46M
-58.02%4.01M
-32.30%2.19M
Total profit
-25.49%1.36B
-25.83%957.97M
-4.88%550.25M
7.02%2.47B
16.00%1.82B
24.85%1.29B
53.54%578.49M
17.02%2.31B
-1.90%1.57B
-9.76%1.03B
Less:Income tax cost
-29.56%260.79M
-28.35%187.91M
-11.50%104.13M
-4.56%514.74M
5.95%370.26M
9.37%262.25M
43.49%117.66M
20.60%539.33M
6.42%349.45M
0.57%239.79M
Net profit
-24.45%1.1B
-25.19%770.05M
-3.19%446.12M
10.54%1.96B
18.87%1.45B
29.52%1.03B
56.33%460.83M
15.98%1.77B
-4.05%1.22B
-12.47%794.77M
Net profit from continuing operation
-24.45%1.1B
-25.19%770.05M
-3.19%446.12M
10.54%1.96B
18.87%1.45B
29.52%1.03B
56.33%460.83M
15.98%1.77B
-4.05%1.22B
-12.47%794.77M
Less:Minority Profit
-88.44%30.13M
-86.66%26.57M
-41.85%57.35M
26.03%359.23M
51.20%260.53M
65.20%199.15M
132.55%98.63M
49.06%285.03M
-12.64%172.3M
-27.62%120.55M
Net profit of parent company owners
-10.43%1.07B
-10.45%743.49M
7.33%388.77M
7.57%1.6B
13.56%1.19B
23.14%830.25M
43.53%362.21M
11.24%1.49B
-2.47%1.05B
-9.07%674.22M
Earning per share
Basic earning per share
-10.75%1.91
-10.07%1.34
7.69%0.7
7.49%2.87
13.83%2.14
23.14%1.49
10.17%0.65
-14.42%2.67
-25.10%1.88
-30.06%1.21
Diluted earning per share
-10.75%1.91
-10.07%1.34
7.69%0.7
7.49%2.87
13.83%2.14
23.14%1.49
10.17%0.65
-14.42%2.67
-25.10%1.88
-30.06%1.21
Other composite income
-41.32%-13.91K
-41.32%-13.91K
100.24%56.31K
-107.43%-9.85K
-160.95%-9.85K
-107.38%-4.77K
15.83%-23.32M
21.42%132.52K
-105.82%-3.77K
Other composite income of parent company owners
-41.32%-13.91K
-41.32%-13.91K
----
100.27%38.05K
-107.43%-9.85K
-160.95%-9.85K
-107.38%-4.77K
15.94%-13.96M
21.42%132.52K
-105.82%-3.77K
Other composite income of minority owners
----
----
----
100.20%18.26K
----
----
----
15.66%-9.36M
----
----
Total composite income
-24.45%1.1B
-25.19%770.04M
-3.19%446.12M
12.02%1.96B
18.86%1.45B
29.52%1.03B
56.30%460.83M
16.57%1.75B
-4.04%1.22B
-12.48%794.77M
Total composite income of parent company owners
-10.43%1.07B
-10.45%743.47M
7.34%388.77M
8.59%1.6B
13.54%1.19B
23.14%830.24M
43.49%362.2M
11.59%1.47B
-2.47%1.05B
-9.08%674.21M
Total composite income of minority owners
-88.44%30.13M
-86.66%26.57M
-41.85%57.35M
30.32%359.25M
51.20%260.53M
65.20%199.15M
132.55%98.63M
53.05%275.67M
-12.64%172.3M
-27.62%120.55M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -0.21%56.47B-1.57%37.79B2.16%19.09B2.77%75.48B3.61%56.59B6.25%38.39B8.96%18.69B7.44%73.44B8.78%54.62B8.94%36.13B
Operating revenue -0.21%56.47B-1.57%37.79B2.16%19.09B2.77%75.48B3.61%56.59B6.25%38.39B8.96%18.69B7.44%73.44B8.78%54.62B8.94%36.13B
Other operating revenue ----8.14%413.53M-----14.71%633.35M----6.18%382.39M----4.59%742.57M----11.90%360.13M
Total operating cost 0.73%55.38B-0.60%37.02B2.54%18.63B2.76%73.28B3.41%54.98B5.99%37.25B8.15%18.17B7.20%71.31B8.75%53.17B9.14%35.14B
Operating cost 0.56%50.33B-0.87%33.64B2.80%17.02B2.96%66.43B3.53%50.05B6.25%33.94B8.71%16.55B6.92%64.52B8.99%48.34B9.32%31.94B
Operating tax surcharges 2.00%141.93M6.00%96M6.61%45.48M-2.14%188.18M-2.31%139.15M-5.56%90.57M1.71%42.66M13.47%192.3M20.03%142.43M26.20%95.9M
Operating expense 2.52%3.94B1.47%2.64B0.11%1.26B1.01%5.33B2.58%3.84B4.70%2.6B4.78%1.26B10.94%5.27B7.37%3.75B7.76%2.49B
Administration expense -4.39%773.75M-3.94%509.77M-5.12%251.65M-2.03%1.11B3.49%809.31M4.17%530.7M0.27%265.24M7.98%1.13B2.89%781.99M3.44%509.46M
Financial expense 47.51%183.06M63.23%120.39M8.10%45.59M7.93%204.54M-18.83%124.1M-33.67%73.76M-29.53%42.17M-10.81%189.51M-7.68%152.89M3.69%111.2M
-Interest expense (Financial expense) 8.20%198.56M21.10%131.09M-7.17%54.75M-5.16%248.38M-10.49%183.51M-24.23%108.24M-18.67%58.98M-9.07%261.91M-7.54%205.02M-2.85%142.86M
-Interest Income (Financial expense) 21.53%-46.62M12.63%-35.05M-5.69%-19.24M-6.33%-77.55M-11.73%-59.4M-15.86%-40.12M-8.53%-18.2M1.83%-72.94M9.42%-53.17M10.66%-34.63M
Research and development 7.16%19.24M7.72%12.97M180.75%6.26M195.81%26.82M--17.96M--12.04M--2.23M--9.07M--------
Credit Impairment Loss 46.24%-46.93M55.64%-27.36M14.17%-40.85M-256.30%-77M-52.10%-87.28M-39.41%-61.69M-83.77%-47.59M49.50%-21.61M-81.87%-57.39M-54.37%-44.25M
Asset Impairment Loss -24.43%-10.76M-284.69%-9.74M27.74%-1.81M75.45%-17.58M19.82%-8.65M61.04%-2.53M-51.64%-2.51M70.53%-71.59M-1,099.11%-10.79M-1,458.75%-6.5M
Other net revenue 20.34%262.69M20.70%186.9M45.44%82M54.70%267.04M90.53%218.29M240.00%154.84M157.10%56.38M50.96%172.62M-57.91%114.57M-73.85%45.54M
Fair value change income -81.93%3.15M-81.93%3.15M-----152.51%-15.16M--17.43M--17.43M------28.87M--------
Invest income 12.27%254.93M22.09%190.06M17.13%102.74M70.36%237.03M103.50%227.06M218.09%155.67M273.86%87.71M-52.41%139.13M-51.95%111.58M-68.75%48.94M
-Including: Investment income associates 33.55%310.43M44.83%227.27M42.41%110.34M5.67%315.45M29.98%232.45M58.72%156.92M86.33%77.48M-10.46%298.53M-24.85%178.84M-37.30%98.87M
Asset deal income -37.29%6.76M-49.84%4.03M69.31%3.01M445.31%45.31M67.65%10.78M151.82%8.04M81.57%1.78M95.71%8.31M566.74%6.43M642.26%3.19M
Other revenue -5.80%55.53M-29.44%26.76M11.32%18.91M5.51%94.44M-8.93%58.95M-14.12%37.92M-32.15%16.99M-13.45%89.51M-6.82%64.74M-6.54%44.16M
Operating profit -26.25%1.34B-26.74%948.86M-5.61%544M7.00%2.47B16.54%1.82B25.45%1.3B53.66%576.35M18.11%2.31B-1.81%1.56B-9.21%1.03B
Add:Non operating Income 139.75%21.91M118.95%12.97M137.14%8.15M96.22%24.45M-0.28%9.14M36.02%5.93M50.18%3.44M-65.73%12.46M-43.37%9.16M-65.13%4.36M
Less:Non operating expense -14.78%9.89M-58.81%3.87M46.00%1.9M150.01%18.65M189.62%11.61M328.13%9.38M116.85%1.3M-46.42%7.46M-58.02%4.01M-32.30%2.19M
Total profit -25.49%1.36B-25.83%957.97M-4.88%550.25M7.02%2.47B16.00%1.82B24.85%1.29B53.54%578.49M17.02%2.31B-1.90%1.57B-9.76%1.03B
Less:Income tax cost -29.56%260.79M-28.35%187.91M-11.50%104.13M-4.56%514.74M5.95%370.26M9.37%262.25M43.49%117.66M20.60%539.33M6.42%349.45M0.57%239.79M
Net profit -24.45%1.1B-25.19%770.05M-3.19%446.12M10.54%1.96B18.87%1.45B29.52%1.03B56.33%460.83M15.98%1.77B-4.05%1.22B-12.47%794.77M
Net profit from continuing operation -24.45%1.1B-25.19%770.05M-3.19%446.12M10.54%1.96B18.87%1.45B29.52%1.03B56.33%460.83M15.98%1.77B-4.05%1.22B-12.47%794.77M
Less:Minority Profit -88.44%30.13M-86.66%26.57M-41.85%57.35M26.03%359.23M51.20%260.53M65.20%199.15M132.55%98.63M49.06%285.03M-12.64%172.3M-27.62%120.55M
Net profit of parent company owners -10.43%1.07B-10.45%743.49M7.33%388.77M7.57%1.6B13.56%1.19B23.14%830.25M43.53%362.21M11.24%1.49B-2.47%1.05B-9.07%674.22M
Earning per share
Basic earning per share -10.75%1.91-10.07%1.347.69%0.77.49%2.8713.83%2.1423.14%1.4910.17%0.65-14.42%2.67-25.10%1.88-30.06%1.21
Diluted earning per share -10.75%1.91-10.07%1.347.69%0.77.49%2.8713.83%2.1423.14%1.4910.17%0.65-14.42%2.67-25.10%1.88-30.06%1.21
Other composite income -41.32%-13.91K-41.32%-13.91K100.24%56.31K-107.43%-9.85K-160.95%-9.85K-107.38%-4.77K15.83%-23.32M21.42%132.52K-105.82%-3.77K
Other composite income of parent company owners -41.32%-13.91K-41.32%-13.91K----100.27%38.05K-107.43%-9.85K-160.95%-9.85K-107.38%-4.77K15.94%-13.96M21.42%132.52K-105.82%-3.77K
Other composite income of minority owners ------------100.20%18.26K------------15.66%-9.36M--------
Total composite income -24.45%1.1B-25.19%770.04M-3.19%446.12M12.02%1.96B18.86%1.45B29.52%1.03B56.30%460.83M16.57%1.75B-4.04%1.22B-12.48%794.77M
Total composite income of parent company owners -10.43%1.07B-10.45%743.47M7.34%388.77M8.59%1.6B13.54%1.19B23.14%830.24M43.49%362.2M11.59%1.47B-2.47%1.05B-9.08%674.21M
Total composite income of minority owners -88.44%30.13M-86.66%26.57M-41.85%57.35M30.32%359.25M51.20%260.53M65.20%199.15M132.55%98.63M53.05%275.67M-12.64%172.3M-27.62%120.55M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data